Found: 8
Select item for more details and to access through your institution.
Antiretroviral activity of the anti-CD4 monoclonal antibody TNX-355 in patients infected with HIV type 1.
- Published in:
- 2004
- By:
- Publication type:
- journal article
A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 10, p. 3067, doi. 10.1210/jc.2011-1256
- By:
- Publication type:
- Article
Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Erratum for: Early weight loss while on lorcaserin, diet, and exercise as a predictor of week 52 weight-loss outcomes.
- Published in:
- Obesity (19307381), 2014, v. 22, n. 12, p. 2641, doi. 10.1002/oby.20947
- By:
- Publication type:
- Article
Early weight loss while on lorcaserin, diet and exercise as a predictor of week 52 weight-loss outcomes.
- Published in:
- Obesity (19307381), 2014, v. 22, n. 10, p. 2137, doi. 10.1002/oby.20841
- By:
- Publication type:
- Article
Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study.
- Published in:
- Obesity (19307381), 2012, v. 20, n. 7, p. 1426, doi. 10.1038/oby.2012.66
- By:
- Publication type:
- Article
Lorcaserin (APD356), a Selective 5-HT<sub>2C</sub> Agonist, Reduces Body Weight in Obese Men and Women.
- Published in:
- Obesity (19307381), 2009, v. 17, n. 3, p. 494, doi. 10.1038/oby.2008.537
- By:
- Publication type:
- Article
Lorcaserin for Smoking Cessation and Associated Weight Gain: A Randomized 12-Week Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article